لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Provenzano R; School of Medicine, Wayne State University, Detroit, Michigan, USA., Fishbane S; Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Great Neck, New York, USA., Szczech L; FibroGen, Inc., San Francisco, California, USA., Leong R; FibroGen, Inc., San Francisco, California, USA., Saikali KG; FibroGen, Inc., San Francisco, California, USA., Zhong M; FibroGen, Inc., San Francisco, California, USA., Lee TT; FibroGen, Inc., San Francisco, California, USA., Houser MT; AstraZeneca, Gaithersburg, Maryland, USA., Frison L; AstraZeneca, Mölndal, Sweden., Houghton J; AstraZeneca, Gaithersburg, Maryland, USA., Little DJ; AstraZeneca, Gaithersburg, Maryland, USA., Peony Yu KH; FibroGen, Inc., San Francisco, California, USA., Neff TB; FibroGen, Inc., San Francisco, California, USA.

المصدر: Kidney international reports [Kidney Int Rep] 2022 Feb 05; Vol. 7 (3), pp. 665. Date of Electronic Publication: 2022 Feb 05 (Print Publication: 2022).

نوع المنشور: Retraction of Publication

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101684752 Publication Model: eCollection Cited Medium: Internet ISSN: 2468-0249 (Electronic) Linking ISSN: 24680249 NLM ISO Abbreviation: Kidney Int Rep Subsets: PubMed not MEDLINE

المؤلفون: Provenzano R; Department of Internal Medicine, Wayne State University, Detroit, Michigan provenzanorobert5@gmail.com., Szczech L; FibroGen, Inc., San Francisco, California., Leong R; FibroGen, Inc., San Francisco, California., Saikali KG; FibroGen, Inc., San Francisco, California., Zhong M; FibroGen, Inc., San Francisco, California., Lee TT; FibroGen, Inc., San Francisco, California., Little DJ; AstraZeneca, Gaithersburg, Maryland., Houser MT; AstraZeneca, Gaithersburg, Maryland., Frison L; AstraZeneca, Mölndal, Sweden., Houghton J; AstraZeneca, Gaithersburg, Maryland., Neff TB; FibroGen, Inc., San Francisco, California.; Deceased.

المصدر: Clinical journal of the American Society of Nephrology : CJASN [Clin J Am Soc Nephrol] 2021 Aug; Vol. 16 (8), pp. 1190-1200.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wolters Kluwer Health Country of Publication: United States NLM ID: 101271570 Publication Model: Print Cited Medium: Internet ISSN: 1555-905X (Electronic) Linking ISSN: 15559041 NLM ISO Abbreviation: Clin J Am Soc Nephrol Subsets: MEDLINE

مواضيع طبية MeSH: Anemia/*drug therapy , Cardiovascular Diseases/*chemically induced , Enzyme Inhibitors/*therapeutic use , Glycine/*analogs & derivatives , Isoquinolines/*therapeutic use , Renal Insufficiency, Chronic/*complications, Aged ; Anemia/blood ; Anemia/etiology ; Clinical Trials, Phase III as Topic ; Enzyme Inhibitors/adverse effects ; Erythrocyte Transfusion ; Female ; Glycine/adverse effects ; Glycine/therapeutic use ; Hemoglobins/metabolism ; Humans ; Hypoxia-Inducible Factor-Proline Dioxygenases/antagonists & inhibitors ; Isoquinolines/adverse effects ; Male ; Middle Aged ; Mortality ; Randomized Controlled Trials as Topic

المؤلفون: Charytan C; Nephrology Associates, PC, Queens, New York, USA., Manllo-Karim R; South Texas Kidney Specialists, PA, McAllen, Teas, USA., Martin ER; South Florida Nephrology Associates, Lauderdale Lakes, Florida, USA., Steer D; Balboa Nephrology Medical Group, La Jolla, California, USA., Bernardo M; Southwest Nephrology Associates, Houston, Texas, USA., Dua SL; Valley Renal Medical Group, Northridge, California, USA., Moustafa MA; South Carolina Nephrology & Hypertension Center, Inc., Orangeburg, South Carolina, USA., Saha G; FibroGen, Inc., San Francisco, California, USA., Bradley C; FibroGen, Inc., San Francisco, California, USA., Eyassu M; FibroGen, Inc., San Francisco, California, USA., Leong R; FibroGen, Inc., San Francisco, California, USA., Saikali KG; FibroGen, Inc., San Francisco, California, USA., Liu C; FibroGen, Inc., San Francisco, California, USA., Szczech L; FibroGen, Inc., San Francisco, California, USA., Yu KP; FibroGen, Inc., San Francisco, California, USA.

المصدر: Kidney international reports [Kidney Int Rep] 2021 Apr 17; Vol. 6 (7), pp. 1829-1839. Date of Electronic Publication: 2021 Apr 17 (Print Publication: 2021).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101684752 Publication Model: eCollection Cited Medium: Internet ISSN: 2468-0249 (Electronic) Linking ISSN: 24680249 NLM ISO Abbreviation: Kidney Int Rep Subsets: PubMed not MEDLINE

المؤلفون: Provenzano R; School of Medicine, Wayne State University, Detroit, Michigan, USA., Fishbane S; Department of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Great Neck, New York, USA., Szczech L; FibroGen, Inc., San Francisco, California, USA., Leong R; FibroGen, Inc., San Francisco, California, USA., Saikali KG; FibroGen, Inc., San Francisco, California, USA., Zhong M; FibroGen, Inc., San Francisco, California, USA., Lee TT; FibroGen, Inc., San Francisco, California, USA., Houser MT; AstraZeneca, Gaithersburg, Maryland, USA., Frison L; AstraZeneca, Mölndal, Sweden., Houghton J; AstraZeneca, Gaithersburg, Maryland, USA., Little DJ; AstraZeneca, Gaithersburg, Maryland, USA., Peony Yu KH; FibroGen, Inc., San Francisco, California, USA., Neff TB; FibroGen, Inc., San Francisco, California, USA.

المصدر: Kidney international reports [Kidney Int Rep] 2020 Dec 24; Vol. 6 (3), pp. 613-623. Date of Electronic Publication: 2020 Dec 24 (Print Publication: 2021).

نوع المنشور: Journal Article; Retracted Publication

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101684752 Publication Model: eCollection Cited Medium: Internet ISSN: 2468-0249 (Electronic) Linking ISSN: 24680249 NLM ISO Abbreviation: Kidney Int Rep Subsets: PubMed not MEDLINE

المؤلفون: Coyne DW; Division of Nephrology, Washington University School of Medicine, St. Louis, Missouri, USA., Roger SD; Renal Unit, Renal Research, Gosford, NSW, Australia., Shin SK; Kidney Center, Ilsan Hospital NHIS, Goyang-si, Gyeongeei-Do, Republic of Korea., Kim SG; Department of Internal Medicine, Hallym University, Chuncheon, Republic of Korea., Cadena AA; Department of Internal Medicine, Clinica de la Costa, Barranquilla, Colombia., Moustafa MA; South Carolina Nephrology and Hypertension Center, Inc., Orangeburg, South Carolina, USA., Chan TM; Department of Medicine, University of Hong Kong, Queen Mary Hospital, HKSAR, Hong Kong, China., Besarab A; School of Medicine Center for Neuroscience in Women's Health, Stanford University, Palo Alto, California, USA., Chou W; Department of Clinical Development, FibroGen, Inc., San Francisco, California, USA., Bradley C; Department of Clinical Development, FibroGen, Inc., San Francisco, California, USA., Eyassu M; Department of Clinical Operations, FibroGen, Inc., San Francisco, California, USA., Leong R; Department of Clinical Development, FibroGen, Inc., San Francisco, California, USA., Lee TT; Department of Biometrics, FibroGen, Inc., San Francisco, California, USA., Saikali KG; Department of Biometrics, FibroGen, Inc., San Francisco, California, USA., Szczech L; Department of Clinical Development, FibroGen, Inc., San Francisco, California, USA., Yu KP; Department of Clinical Development, FibroGen, Inc., San Francisco, California, USA.

المصدر: Kidney international reports [Kidney Int Rep] 2020 Dec 05; Vol. 6 (3), pp. 624-635. Date of Electronic Publication: 2020 Dec 05 (Print Publication: 2021).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101684752 Publication Model: eCollection Cited Medium: Internet ISSN: 2468-0249 (Electronic) Linking ISSN: 24680249 NLM ISO Abbreviation: Kidney Int Rep Subsets: PubMed not MEDLINE

المؤلفون: Provenzano R; St. John Hospital and Medical Center, Detroit, Michigan., Besarab A; FibroGen, Inc., San Francisco, California., Sun CH; Apex Research of Riverside, Riverside, California., Diamond SA; San Antonio Kidney Disease Center, San Antonio, Texas., Durham JH; Palmetto Nephrology, Professional Association, Orangeburg, South Carolina., Cangiano JL; Nephrology Private Practice, San Juan, Puerto Rico., Aiello JR; Mountain Kidney and Hypertension Associates, Professional Association, Asheville, North Carolina; and., Novak JE; Division of Nephrology, Henry Ford Hospital, Detroit, Michigan., Lee T; FibroGen, Inc., San Francisco, California., Leong R; FibroGen, Inc., San Francisco, California., Roberts BK; FibroGen, Inc., San Francisco, California., Saikali KG; FibroGen, Inc., San Francisco, California., Hemmerich S; FibroGen, Inc., San Francisco, California., Szczech LA; FibroGen, Inc., San Francisco, California., Yu KP; FibroGen, Inc., San Francisco, California., Neff TB; FibroGen, Inc., San Francisco, California.

المصدر: Clinical journal of the American Society of Nephrology : CJASN [Clin J Am Soc Nephrol] 2016 Jun 06; Vol. 11 (6), pp. 982-991. Date of Electronic Publication: 2016 Apr 19.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial

بيانات الدورية: Publisher: Wolters Kluwer Health Country of Publication: United States NLM ID: 101271570 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1555-905X (Electronic) Linking ISSN: 15559041 NLM ISO Abbreviation: Clin J Am Soc Nephrol Subsets: MEDLINE

مواضيع طبية MeSH: Anemia/*drug therapy , Enzyme Inhibitors/*therapeutic use , Glycine/*analogs & derivatives , Isoquinolines/*therapeutic use , Renal Insufficiency, Chronic/*complications, Administration, Oral ; Adult ; Aged ; Aged, 80 and over ; Anemia/blood ; Anemia/etiology ; C-Reactive Protein/metabolism ; Cholesterol/blood ; Enzyme Inhibitors/administration & dosage ; Enzyme Inhibitors/adverse effects ; Female ; Glycine/administration & dosage ; Glycine/adverse effects ; Glycine/therapeutic use ; Hemoglobins/metabolism ; Hepcidins/blood ; Humans ; Hypoxia-Inducible Factor-Proline Dioxygenases/antagonists & inhibitors ; Isoquinolines/administration & dosage ; Isoquinolines/adverse effects ; Male ; Middle Aged

المؤلفون: Provenzano R; St. John Hospital & Medical Center, Detroit, MI., Besarab A; FibroGen, Inc, San Francisco, CA., Wright S; US Renal Care, Pine Bluff, AR., Dua S; Valley Renal Medical Group, Northridge, CA., Zeig S; Pines Clinical Research, Pembroke Pines, FL., Nguyen P; US Renal Care, Ft Worth, TX., Poole L; FibroGen, Inc, San Francisco, CA., Saikali KG; FibroGen, Inc, San Francisco, CA., Saha G; FibroGen, Inc, San Francisco, CA., Hemmerich S; FibroGen, Inc, San Francisco, CA., Szczech L; FibroGen, Inc, San Francisco, CA., Yu KH; FibroGen, Inc, San Francisco, CA. Electronic address: pyu@fibrogen.com., Neff TB; FibroGen, Inc, San Francisco, CA.

المصدر: American journal of kidney diseases : the official journal of the National Kidney Foundation [Am J Kidney Dis] 2016 Jun; Vol. 67 (6), pp. 912-24. Date of Electronic Publication: 2016 Feb 02.

نوع المنشور: Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial

بيانات الدورية: Publisher: W.B. Saunders Country of Publication: United States NLM ID: 8110075 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1523-6838 (Electronic) Linking ISSN: 02726386 NLM ISO Abbreviation: Am J Kidney Dis Subsets: MEDLINE

مواضيع طبية MeSH: Renal Dialysis*, Anemia/*drug therapy , Epoetin Alfa/*therapeutic use , Glycine/*analogs & derivatives , Hematinics/*therapeutic use , Isoquinolines/*therapeutic use , Kidney Failure, Chronic/*complications , Kidney Failure, Chronic/*therapy, Adult ; Aged ; Aged, 80 and over ; Epoetin Alfa/administration & dosage ; Female ; Glycine/administration & dosage ; Glycine/therapeutic use ; Hematinics/administration & dosage ; Humans ; Isoquinolines/administration & dosage ; Male ; Middle Aged ; Time Factors ; Treatment Outcome ; Young Adult

المؤلفون: Besarab A; FibroGen, Inc., San Francisco, California; abesarab@fibrogen.com., Chernyavskaya E; Budgetary Healthcare Institution of Omsk Region, City Clinical Hospital #1, Omsk, Russia;, Motylev I; City Hospital #33, Nizhny Novgorod, Russia;, Shutov E; State Budgetary Healthcare Institution of Moscow, City Clinical Hospital, Moscow, Russia;, Kumbar LM; Division of Nephrology and Hypertension, Henry Ford Hospital, Detroit, Michigan;, Gurevich K; Fresenius Medical Care, St. Petersburg, Russia; and., Chan DT; Division of Nephrology, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong., Leong R; FibroGen, Inc., San Francisco, California;, Poole L; FibroGen, Inc., San Francisco, California;, Zhong M; FibroGen, Inc., San Francisco, California;, Saikali KG; FibroGen, Inc., San Francisco, California;, Franco M; FibroGen, Inc., San Francisco, California;, Hemmerich S; FibroGen, Inc., San Francisco, California;, Yu KH; FibroGen, Inc., San Francisco, California;, Neff TB; FibroGen, Inc., San Francisco, California;

المصدر: Journal of the American Society of Nephrology : JASN [J Am Soc Nephrol] 2016 Apr; Vol. 27 (4), pp. 1225-33. Date of Electronic Publication: 2015 Oct 22.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wolters Kluwer Health, on behalf of the American Society of Nephrology Country of Publication: United States NLM ID: 9013836 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-3450 (Electronic) Linking ISSN: 10466673 NLM ISO Abbreviation: J Am Soc Nephrol Subsets: MEDLINE

مواضيع طبية MeSH: Renal Dialysis*, Anemia/*drug therapy , Glycine/*analogs & derivatives , Isoquinolines/*therapeutic use, Anemia/blood ; Female ; Glycine/therapeutic use ; Hepcidins/blood ; Humans ; Male ; Middle Aged ; Peritoneal Dialysis

المؤلفون: Greenberg BH; University of California at San Diego, San Diego, California. Electronic address: bgreenberg@ucsd.edu., Chou W; Cytokinetics, Inc., South San Francisco, California., Saikali KG; Cytokinetics, Inc., South San Francisco, California., Escandón R; Cytokinetics, Inc., South San Francisco, California., Lee JH; Cytokinetics, Inc., South San Francisco, California., Chen MM; Cytokinetics, Inc., South San Francisco, California., Treshkur T; Almazov Federal Heart Blood and Endocrinology Centre, St. Petersburg, Russia., Megreladze I; Cardiology Clinic, Tbilisi, Georgia., Wasserman SM; Amgen Inc., Thousand Oaks, California., Eisenberg P; Amgen Inc., Thousand Oaks, California., Malik FI; Cytokinetics, Inc., South San Francisco, California., Wolff AA; Cytokinetics, Inc., South San Francisco, California., Shaburishvili T; Diagnostic Services Clinic, Tbilisi, Georgia.

المصدر: JACC. Heart failure [JACC Heart Fail] 2015 Jan; Vol. 3 (1), pp. 22-29. Date of Electronic Publication: 2014 Nov 11.

نوع المنشور: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101598241 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2213-1787 (Electronic) Linking ISSN: 22131779 NLM ISO Abbreviation: JACC Heart Fail Subsets: MEDLINE

مواضيع طبية MeSH: Drug Tolerance*, Angina Pectoris/*drug therapy , Exercise/*physiology , Myocardial Contraction/*drug effects , Myocardial Ischemia/*drug therapy , Urea/*analogs & derivatives, Administration, Oral ; Adult ; Aged ; Aged, 80 and over ; Angina Pectoris/diagnosis ; Angina Pectoris/physiopathology ; Dose-Response Relationship, Drug ; Double-Blind Method ; Exercise Test ; Female ; Follow-Up Studies ; Georgia (Republic) ; Humans ; Male ; Middle Aged ; Myocardial Ischemia/diagnosis ; Myocardial Ischemia/physiopathology ; Retrospective Studies ; Russia ; Treatment Outcome ; Urea/administration & dosage